RA
REPL icon

Rosalind Advisors’s Replimune Group REPL Stock Holding History

Rosalind Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,410,497
Closed -$10.8M – 42
2025
Q4 		$13.7M Buy
+1,410,497
New +$12M 4.82% 8
2025
Q3 		– Sell
-900,000
Closed -$5.75M – 46
2025
Q2 		$8.36M Buy
900,000
+50,000
+6% +$436K 3.96% 10
2025
Q1 		$8.29M Buy
850,000
+590,000
+227% +$7.3M 4.03% 10
2024
Q4 		$3.15M Buy
+260,000
New +$3.16M 1.61% 19

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Rosalind Advisors's REPL Position: Q1 2026 in Review

Rosalind Advisors sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 1,410,497 shares — an estimated $10.8M sold.

Rosalind Advisors first reported a position in REPL in Q4 2024 and held it in 4 quarters. The position peaked at $13.7M in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Rosalind Advisors reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • Rosalind Advisors sold 1,410,497 Replimune Group shares in Q1 2026, an estimated $10.8M.
  • Rosalind Advisors first reported a position in Replimune Group in Q4 2024 and held it in 4 quarters.
  • Rosalind Advisors's Replimune Group position peaked at $13.7M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Rosalind Advisors's 13F filing for Q1 2026, filed 14 May 2026.